Johns EC, Denison FC, Norman JE, Reynolds RM. Gestational diabetes mellitus: mechanisms, treatment, and complications. Trends Endocrinol Metab. 2018;29:743–54.
Article CAS PubMed Google Scholar
Moon JH, Jang HC. Gestational diabetes mellitus: diagnostic approaches and Maternal-Offspring complications. Diabetes Metab J. 2022;46:3–14.
Article PubMed PubMed Central Google Scholar
Hod M, Kapur A, McIntyre HD, FIGO WGOH, FIGO P. A. P. O.Evidence in support of the international association of diabetes in pregnancy study groups’ criteria for diagnosing gestational diabetes mellitus worldwide in 2019. Am J Obstet Gynecol. 2019;221:109–16.
Łoś K, Waszkiewicz NB. Markers Anxiety Disorders J Clin Med. 2021;10:1744.
Allahverdy J, Rashidi NM. Induced by Listeria Monocytogenes and their role in cells. Microb Pathog. 2023;175:105997.
Article CAS PubMed Google Scholar
Lu W, Hu CM. Biomarkers for gestational diabetes mellitus and postpartum diabetes. Chin Med J (Engl). 2022;135:1940–51.
Serati A, Novielli C, Anelli GM, Mandalari M, Parisi F, Cetin I, et al. Characterization of maternal Circulating Micrornas in obese pregnancies and gestational diabetes mellitus.antioxidants. (Basel). 2023;12:515.
Wang P, Ma Z, Wang Z, Wang X, Zhao G, Wang Z, et al. Mir-6869-5P induces M2 polarization by regulating Ptpro in gestational diabetes mellitus. Mediators Inflamm. 2021;2021:6696636–8.
Article PubMed PubMed Central Google Scholar
Lino CA, de Oliveira-Silva T, Lunardon G, Balbino-Silva C, Lima VM, Huang Z, et al. Ablation of Mirna-22 protects against Obesity-Induced adipocyte senescence and ameliorates metabolic disorders in Middle-Aged mice. Mech Ageing Dev. 2023;210:111775.
Article CAS PubMed Google Scholar
Prukpitikul P, Sirivarasai J, Sutjarit NT. Molecular mechanisms underlying gut Microbiota-Mirna interaction in metabolic disorders. Benef Microbes. 2024;15:83–96.
Article CAS PubMed Google Scholar
Masete M, Dias S, Malaza N, Adam S, Pheiffer. C.A big role for Micrornas in gestational diabetes mellitus.frontiers in endocrinology. (Lausanne). 2022;13:892587.
Zhao Q, Li B, Zhang X, Zhao H, Xue W, Yuan Z, et al. M2 Macrophage-Derived Lncrna Norad in Evs promotes Nsclc progression via Mir-520G-3P/Smim22/Gale Axis. NPJ Precis Oncol. 2024;8:185.
Article CAS PubMed PubMed Central Google Scholar
Zhang X, Hu Z, Li W, Liu Z, Li J, Wang Z, et al. Circular Rna 0102049 suppresses the progression of osteosarcoma through modulating Mir-520G-3P/Plk2. Axis Bioengineered. 2021;12:2022–32.
Article CAS PubMed Google Scholar
Staynova R, Vasileva E, Yanachkova VG. Diabetes mellitus: A growing economic concern. Folia Med (Plovdiv). 2022;64:725–32.
Xu H, Liu RC. Management of gestational diabetes mellitus: practical efficacy of exercise therapy and sustained intervention strategies. Front Endocrinol (Lausanne). 2024;15:1347754.
Zhang Q, Ye X, Xu X, Yan JP. -Derived Exosomal Mir‐135a‐5P promotes gestational diabetes mellitus pathogenesis by activating Pi3K/Akt signalling pathway via Sirt1.J cell. Mol Med. 2023;27:3729–43.
Juchnicka I, Kuzmicki M. Influence of Mirnas in gestational diabetes mellitus development. Ginekol Pol. 2021;92:579–82.
Dinesen S, El-Faitarouni A, Dalgaard L. T.Circulating Micrornas associated with gestational diabetes mellitus. Useful Biomarkers?J Endocrinol 2023;256.
Ghaneialvar H, Mohseni MM, Kenarkoohi A, Kakaee SA. Mir-26a and Mir-26B Micrornas potent prognostic markers of gestational Diabetes?Health. Sci Rep. 2024;7:e2152.
Wang F, Li Z, Zhao M, Ye W, Wu H, Liao Q, et al. Circulating Mirnas Mir-574-5P and Mir-3135B are potential metabolic regulators for serum lipids and blood glucose in gestational diabetes mellitus. Gynecol Endocrinol. 2021;37:665–71.
Article CAS PubMed Google Scholar
Juchnicka I, Kuźmicki M, Niemira M, Bielska A, Sidorkiewicz I, Zbucka-Krętowska M, et al. Mirnas as predictive factors in early diagnosis of gestational diabetes mellitus.frontiers in endocrinology. (Lausanne). 2022;13:839344.
Li W, Yuan X, He X, Yang L, Wu Y, Deng X, et al. The downregulation of Mir-22 and Mir-372 May contribute to gestational diabetes mellitus through regulating glucose metabolism via the Pi3K/Akt/Glut4 pathway. J Clin Lab Anal. 2022;36:e24557.
Article CAS PubMed PubMed Central Google Scholar
Rao J, Chen Y, Huang J, Wu R, Dong Z, Gao Y, et al. Inhibiting Mir-182-3P alleviates gestational diabetes mellitus by improving insulin resistance in skeletal muscle. Balkan Med J. 2022;39:121–9.
Comments (0)